Total Payments
$26,870
2024 Payments
$4,183
Companies
81
Transactions
1,808
Medicare Patients
6,915
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$26,559 (98.8%)
Other$171.90 (0.6%)
Education$138.52 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $26,559 | 1,787 | 98.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $171.90 | 13 | 0.6% |
| Education | $138.52 | 8 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $2,567 | 291 | $0 (2024) |
| ABBVIE INC. | $1,988 | 133 | $0 (2024) |
| Biogen, Inc. | $1,707 | 105 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,464 | 89 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,416 | 116 | $0 (2024) |
| Allergan, Inc. | $1,344 | 94 | $0 (2022) |
| UCB, Inc. | $1,295 | 78 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $971.53 | 82 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $857.27 | 45 | $0 (2024) |
| Amgen Inc. | $719.13 | 43 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,183 | 227 | ABBVIE INC. ($498.00) |
| 2023 | $4,374 | 231 | AbbVie Inc. ($477.04) |
| 2022 | $3,421 | 214 | ABBVIE INC. ($492.70) |
| 2021 | $2,933 | 219 | AbbVie Inc. ($413.18) |
| 2020 | $2,701 | 219 | EMD Serono, Inc. ($557.86) |
| 2019 | $3,777 | 359 | EMD Serono, Inc. ($574.77) |
| 2018 | $2,844 | 211 | Teva Pharmaceuticals USA, Inc. ($433.67) |
| 2017 | $2,638 | 128 | Allergan Inc. ($324.19) |
All Payment Transactions
1,808 individual payment records from CMS Open Payments — Page 1 of 73
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Neurology | ||||||
| 12/23/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.19 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Neuroscience | ||||||
| 12/18/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Neurology | ||||||
| 12/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Neurology | ||||||
| 12/09/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.87 | General |
| 12/09/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Neurology | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Rare Disease | ||||||
| 12/02/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: RETT SYNDROME | ||||||
| 11/25/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: Neurology | ||||||
| 11/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $4.43 | General |
| 11/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $30.13 | General |
| 11/18/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: EPILEPSY | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: PAIN | ||||||
| 11/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,902 | 55,142 | $2.2M | $533,855 |
| 2022 | 26 | 1,865 | 44,414 | $1.7M | $426,967 |
| 2021 | 25 | 1,763 | 20,451 | $1.2M | $286,616 |
| 2020 | 22 | 1,385 | 12,241 | $808,058 | $170,493 |
Total Patients
6,915
Total Services
132,248
Medicare Billing
$1.4M
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3032 | Injection, eptinezumab-jjmr, 1 mg | Office | 2023 | 41 | 14,500 | $759,075 | $189,744 | 25.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 33 | 17,785 | $168,958 | $87,708 | 51.9% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2023 | 23 | 18,300 | $219,600 | $73,068 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 600 | 854 | $405,650 | $70,542 | 17.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 194 | 194 | $93,508 | $22,445 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 285 | 323 | $80,750 | $17,622 | 21.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 74 | 74 | $44,992 | $9,171 | 20.4% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 96 | 96 | $120,000 | $8,698 | 7.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 28 | 71 | $31,311 | $7,868 | 25.1% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 65 | 114 | $19,038 | $4,779 | 25.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 37 | 37 | $21,164 | $4,717 | 22.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 50 | 94 | $19,740 | $4,187 | 21.2% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 24 | 74 | $15,614 | $3,777 | 24.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 13 | 13 | $13,208 | $3,517 | 26.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 75 | $9,225 | $3,270 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 25 | $13,125 | $3,207 | 24.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 43 | 47 | $16,450 | $3,123 | 19.0% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 19 | 21 | $29,904 | $2,542 | 8.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 15 | 26 | $15,600 | $2,310 | 14.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 25 | 25 | $14,475 | $2,263 | 15.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 13 | 13 | $8,892 | $1,915 | 21.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $6,594 | $1,624 | 24.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 40 | 40 | $5,040 | $1,512 | 30.0% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 11 | 23 | $6,854 | $1,407 | 20.5% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 17 | 17 | $6,188 | $1,309 | 21.2% |
About Dr. Stephen Donahue, MD
Dr. Stephen Donahue, MD is a Neurology healthcare provider based in Savannah, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2010. The National Provider Identifier (NPI) number assigned to this provider is 1164746624.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Donahue, MD has received a total of $26,870 in payments from pharmaceutical and medical device companies, with $4,183 received in 2024. These payments were reported across 1,808 transactions from 81 companies. The most common payment nature is "Food and Beverage" ($26,559).
As a Medicare-enrolled provider, Donahue has provided services to 6,915 Medicare beneficiaries, totaling 132,248 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Savannah, GA
- Active Since 03/26/2010
- Last Updated 05/15/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1164746624
Products in Payments
- ACTHAR (Biological) $1,339
- BOTOX (Biological) $1,228
- TYSABRI (Biological) $1,110
- APTIOM (Drug) $1,011
- UBRELVY (Drug) $966.13
- NURTEC ODT (Drug) $770.44
- Briviact (Drug) $685.39
- Aimovig (Biological) $658.95
- KESIMPTA (Drug) $616.36
- Mavenclad (Drug) $583.47
- Mavenclad (Biological) $481.49
- VYEPTI (Biological) $480.44
- QULIPTA (Drug) $457.71
- Fycompa (Drug) $443.71
- VALTOCO (Drug) $421.16
- GILENYA (Drug) $380.19
- MAVENCLAD (Drug) $380.12
- ULTOMIRIS (Biological) $368.39
- AJOVY (Drug) $362.55
- Hizentra (Biological) $350.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Savannah
Victor Rosenfeld, M.d, M.D
Neurology — Payments: $413,963
Neurology $413,963
Robert Macgregor, M.d, M.D
Neurology — Payments: $51,325
Neurology $51,325
Dr. Brandi Fleenor, Md, MD
Neurology — Payments: $45,288
Neurology $45,288
Dr. Joel Greenberg, M.d, M.D
Neurology — Payments: $38,325
Neurology $38,325
Dr. James Sutton, M.d, M.D
Neurology — Payments: $18,745
Neurology $18,745
Jay Schecter, Md, MD
Neurology — Payments: $17,868
Neurology $17,868